第2段增加了背景，第3段增加了合作细节
路透哥本哈根6月23日 - 诺和诺德NOVOb.CO周一表示，将停止与Hims & Hers HealthHIMS.N 在销售减肥药方面的合作。
两家公司 曾于4月份宣布 (link) ，Hims & Hers将通过远程医疗公司的平台捆绑销售诺和诺德的大片Wegovy减肥药。
诺和诺德公司周一在一份声明中表示，Hims & Hers Health公司将不再通过NovoCare药房直接购买Wegovy。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.